3D printing in healthcare market seen nearly doubling by 2030

The Business Research Company says the global 3D printing in healthcare market will grow from $2.47 billion in 2025 to $5.99 billion by 2030, driven by demand for personalized devices, bioprinting and point-of-care manufacturing. North America led in 2025, while Asia Pacific is forecast to be the fastest-growing region.

Why it matters: - 3D printing is moving from niche medical use to a broader tool for personalized care, device manufacturing and surgical planning. - The market’s projected growth signals rising demand for patient-specific implants, models and instruments across healthcare systems. - The trend matters for providers, device makers and researchers as chronic disease rates and regulatory approvals continue to shape adoption.

What happened: - The Business Research Company released its 3D Printing In Healthcare Market Report 2026 on July 23, 2026. - The report puts the market at $2.47 billion in 2025 and forecasts $2.95 billion in 2026. - The report expects the market to reach $5.99 billion by 2030. - The report covers global market size, trends, regional growth and forecast data through 2035.

The details: - The report says the market will grow at a 19.3% compound annual growth rate in 2026 and a 19.4% CAGR through 2030. - Growth drivers include advances in additive manufacturing, early use of 3D-printed surgical guides, academic research, anatomical models and printable biomaterials. - The report points to rising funding for bioprinting research, stronger demand for personalized healthcare products, wider use in regenerative medicine, more point-of-care manufacturing and more regulatory approvals for printed medical devices. - Key trends listed in the report include patient-specific medical devices, bioprinting technologies, customized surgical models, 3D-printed implants and prosthetics, and tighter integration of digital design with manufacturing. - 3D printing in healthcare refers to building three-dimensional objects layer by layer from a digital design for medical use. - The technology is used for patient-specific medical devices, anatomical models for education and surgery planning, and customized surgical instruments. - The report says chronic disease growth is a major driver of demand. - A June 2024 UK National Health Service update showed 3,615,330 people registered with general practitioners were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, up 18% from 3,065,825 in 2022. - In 2025, North America held the largest share of the market. - Asia Pacific is expected to post the fastest growth during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and future trend analysis. - The report offers a free sample at download a free sample. - The full report is available at view the full report.

Between the lines: - The forecast suggests healthcare adoption is broadening beyond prototyping into routine clinical and manufacturing workflows. - North America’s lead points to mature infrastructure and faster technology uptake, while Asia Pacific’s growth outlook suggests new investment and demand for personalized care are spreading. - The chronic disease data supports the case for more customized devices and treatment tools, especially as patient volumes rise.

What's next: - The report expects continued expansion in bioprinting, regenerative medicine and point-of-care production. - Regulatory approvals will likely remain a key gating factor for broader use of printed medical devices. - More hospitals and manufacturers may adopt digital-to-physical workflows as design and manufacturing systems become more integrated.

The bottom line: - 3D printing in healthcare is still a small market, but the growth trajectory is steep and increasingly tied to personalized medicine and medical device innovation.